$BBIO news
The latest BBIO stock news: headlines, filings, AI summaries and sentiment for $BBIO, updated around the clock.
- BridgeBio Pharma Reports Strong Q3 2026 Revenue Growth Driven by Attruby Expansion
- BridgeBio Pharma Announces Upcoming Product Launches and Key PDUFA Dates
- BridgeBio Pharma, Inc. - 10-Q Filing
- BridgeBio Pharma Reports Third Quarter Revenue Growth and EPS Beat
- BridgeBio Pharma, Inc. - 8-K Filing
- BridgeBio Pharma, Inc. - 8-K Filing
- BridgeBio Reports Positive Phase 3 Trial Results for Rare-Disease Drug Encaleret
- BridgeBio's Infigratinib Receives Priority Review for Achondroplasia
- BridgeBio's Attruby Outperforms Pfizer’s Vyndamax in Real-World Study
- BridgeBio Pharma, Inc. - 8-K Filing
- BridgeBio Reports Q2 2026 Earnings: Revenue Growth and Regulatory Milestones
- Alnylam Shares Drop Nearly 30% After Earnings Report and Guidance Cut
- BridgeBio Pharma, Inc. - 8-K Filing
- AstraZeneca and Ionis Pharmaceuticals' Phase 3 Trial Failure Impacts Biotech Market Dynamics
- BridgeBio Stock Rises Following AstraZeneca and Ionis' Failed Heart Drug Trial
- BridgeBio Stock Surges Following AstraZeneca and Ionis' Failed Heart Drug Trial
- BridgeBio Pharma, Inc. - 8-K Filing
- BridgeBio (BBIO) Q1 2026 Earnings Report Shows Strong Revenue Growth
- BridgeBio Pharma, Inc. - 8-K Filing
- BridgeBio Pharma, Inc. - 10-Q Filing
- BridgeBio Pharma, Inc. - 8-K Filing
- BridgeBio Reports Q2 2025 Earnings with Strong Revenue Growth